Innovative Partnership Enhances Diagnostic Solutions Efficiency
Partnership Overview
Immundiagnostik, Inc. has formed an exciting partnership with Epitope Diagnostics, Inc. This collaboration is aimed at enhancing access to innovative solutions that significantly improve efficiency and accuracy for clinical and research laboratories.
The ECL100: A Game-Changer in Laboratory Operations
One of the primary outcomes of this partnership is the introduction of the ECL100, a fully automated chemiluminescent immunoassay analyzer. This sophisticated tool, along with over 50 CLIA kits, promises to boost laboratory capabilities across North America. The ECL100 specializes in catering to the demanding needs of clinical organizations by providing high-quality and efficient testing solutions, a crucial factor in improving workflows and clinical outcomes.
Efficiency at Its Best
With the ability to run between 120 to 180 tests each hour, the ECL100 allows laboratories to handle substantial workloads without compromising accuracy. This level of efficiency is vital as the demand for quick and reliable testing continues to escalate.
Cost-Effective Solutions
Utilizing the ECL100 translates into significant time and cost savings for laboratories. The system requires just a single technician for operation and limits the need for excess consumables and calibrations. Moreover, its built-in refrigeration feature enables laboratories to preload assays, which simplifies workflows and further enhances productivity.
Compatibility with CLIA Kits
The ECL100 is designed to be seamlessly compatible with over 50 CLIA kits. This includes 14 new assays targeting crucial gastrointestinal markers such as calprotectin, C. difficile, H. pylori, pancreatic elastase, and pepsinogen. Having this diversity readily available empowers laboratories to expand their testing capabilities swiftly and efficiently.
Industry Challenges and Solutions
Terry Fisher, the Chief Operations Officer at Immundiagnostik, expressed enthusiasm about this partnership, emphasizing the need for innovative tools to help laboratory personnel navigate the challenges posed by technician shortages and increasing demands for quicker testing results. The ECL100, combined with its broad assay menu, offers labs the flexibility required to maintain high standards of testing while optimizing their resources.
A Collaborative Vision
The collaboration between Immundiagnostik, Inc. and Epitope Diagnostics, Inc. aims not only to address current industry challenges but also to empower laboratories with cutting-edge tools capable of enhancing clinical outcomes. The merger of expertise from both companies fosters a stronger foundation for diagnostic advancements.
About Immundiagnostik, Inc.
Immundiagnostik, Inc. stands out as a leader in providing immunoassays and laboratory detection tools specifically designed for research and clinical laboratories throughout North America. With a dedication to delivering high-quality solutions, Immundiagnostik focuses on enriching laboratory efficiency and accuracy.
About Epitope Diagnostics, Inc.
Founded in 2003, Epitope Diagnostics, Inc. (EDI) is committed to developing and manufacturing innovative in-vitro diagnostics (IVD) products. EDI’s mission is to meet the evolving needs of the global healthcare community, aiming to address critical medical needs through the advancement of diagnostic technologies.
Contact Information
For further inquiries regarding the ECL100 and compatible CLIA kits, contact Immundiagnostik, Inc.:
Noelle Hurley
Phone: 888-433-9020, x. 1009
Email: noelle.hurley@idkna.com
Website: www.idkna.com
Frequently Asked Questions
What is the ECL100?
The ECL100 is a fully automated chemiluminescent immunoassay analyzer designed to enhance laboratory efficiencies and streamline testing operations.
What benefits does the partnership between Immundiagnostik and Epitope Diagnostics provide?
This partnership enhances access to innovative testing solutions, allowing laboratories to improve workflows and clinical outcomes effectively.
How many tests can the ECL100 run per hour?
It can process between 120 to 180 tests per hour, significantly boosting laboratory output.
What types of assays does the ECL100 support?
The ECL100 is compatible with over 50 CLIA kits, including assays for essential gastrointestinal markers.
Who can I contact for more information about Immundiagnostik?
You can reach out to Noelle Hurley at Immundiagnostik, Inc. via phone or email for inquiries about their products and services.
About The Author
Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
